InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Patou, Gary. Director active across 2 companies, notably Xenon Pharmaceuticals Inc.. In total, 5 filings have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €44k. History available since 5 June 2026. The latest transaction was disclosed on 5 June 2026 (10 - Acquisition or disposition in the public market). Regulator: SEC (Form 4). All data is free.
5 of 5 declarations